Order by most recent / most popular / relevance
Results: 1-5 of 5
In Canada, drugs that are classified as "Innovative drugs" are eligible for eight years of data protection (data exclusivity). In April 2012, the
In Canada, innovative drugs are eligible for eight years of data exclusivity under section C.08.004.1 of the Food and Drug Regulations (the
Amgen recently started litigation against Teva over the biologic drug filgrastim (Court File No. T-989-12
Innovative drugs are eligible for eight years of data protection (data exclusivity) in Canada
Social media marketing may be used to promote pharmaceuticals in Canada
